M.D., Ph.D., Professor of Cancer Medicine and Medical Oncology, Imperial College/ Imperial Healthcare NHS Trust
After completion of junior doctor posts in Oxford, Professor Stebbing undertook training and a residency program at The Johns Hopkins Hospital in the US, returning to London to continue his career in oncology at The Royal Marsden and then St Bartholomew’s Hospitals. He has published 600 peer-reviewed papers in journals such as the Lancet, New England Journal, and Annals of Internal Medicine. His focus at Imperial is on new therapies in cancer. He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists. Recently, Justin’s team published in Nature Medicine the discovery of a new cancer-causing gene, implicated in breast, gastro-intestinal, lung and other solid tumors. The National Institute for Health Research (NIHR) awarded Justin its first translational research professorship in oncology. In 2016 Justin was internationally recognized with his appointment as Editor-in-Chief of Oncogene, and election to the American Society for Clinical Investigation.